Short-Term Debt to Equity Ratio: Catalyst Pharmaceuticals (CPRX)
Catalyst Pharmaceuticals (CPRX) specializes in the therapy of rare brain pathologies, leveraging its status as a reliable provider among medical professionals. However, the business remains vulnerable due to its dependence on a single drug and geopolitical disruptions in raw material logistics. The market trend for the asset on the GURU.Markets price chart, where the metric stands at 0.00, confirms the company's resilience to patent threats and regulatory pressure.
Metric breakdowns and analytics for catalystpharma.com (CPRX)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Catalyst Pharmaceuticals|CPRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Catalyst Pharmaceuticals, Inc.|CPRX - Company Aggregate Debts|Debt to Book Value Catalyst Pharma|CPRX - Amount of Long-Term Liabilities|Company Short-Term Debts Catalyst Pharmaceuticals|Quick Liquidity catalystpharma.com
- company profitability and valuation multiples indicators:
Comprehensive company analysis:Catalyst Pharmaceuticals Inc CPRX
The pricing power of Catalyst Pharmaceuticals (CPRX) in the orphan drug niche minimizes operational risks, allowing the company to effectively manage liquidity even during market downturns. By analyzing the history of short-term loan shares in equity, an investor assesses the ratio of short-term liabilities with a maturity of over one year to equity, where a decrease in this metric confirms financial stability and the absence of cash gap threats.
Key competitors
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|DNLI (Denali Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio harmonybiosciences.com (HRMY)|Short-Term Debt to Capital BHVN|Short-Term Debt to Capital Amylyx Pharmaceuticals Inc (AMLX)|Trevi Pharma - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio PRAX (Praxis Corp)|Anavex Life Sciences - Short-Term Debt to Capital|CBLL - Short-Term Debt to Capital|Prothena Corp (PRTA) - Short-Term Debt to Equity|ALEC (Alector) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio ANNX|Current Liabilities to Capital Omeros Corp. OMER|Short-Term Debt to Equity Neurogene Inc. (NGNE)|Short-Term Debt to Capital Coefficient acimmune.com|Voyager Therapeutics, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio NMRA (Neumora)|SCLX: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital TVGN (Tevogen Bio Inc.)|alphacognition.com (ACOG) - Short-Term Debt to Equity|Current Liabilities to Equity CGTX (cogrx.com)|IKT (Inhibikase Therapeutics, Inc.) - Short-Term Debt to Capital|SAVA: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ASRT|Short-Term Debt to Capital coyatherapeutics.com (COYA)|Short-Term Debt to Equity Vistagen VTGN|Ratio of Short-Term Indebtedness to Capital OVID|ABOS - Short-Term Debt to Equity|CervoMed, Inc. (CRVO) - Short-Term Debt to Equity Ratio|ATHE: Short-Term Debt to Capital|Clene (CLNN) - Short-Term Debt to Capital|PEPG (PepGen Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio jupiterneurosciences.com (JUNS)|Short-Term Debt to Capital RLMD|ANVS - Current Liabilities to Capital|Grace Therapeutics - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Firefly Neuro AIFF|KLTO: Short-Term Debt to Equity Ratio|NeuroSense Therapeutics - Short-Term Loans to Capital Ratio|RVPH: Short-Term Debt to Capital|MTVA - Short-Term Debt to Capital Coefficient|NRXS (NeurAxis, Inc) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Helius Medical Technologies Inc. (HSDT)|Short-Term Debt to Capital PASG|Short-Term Debt to Capital bionomics.com.au (NEUP)|Short-Term Debt to Equity Minerva Neurosciences, Inc. NERV|Athira Pharma Inc - Short-Term Debt to Equity|ADXN - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Alzamend Neuro, Inc. ALZN|CYCN: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Protagenic Therapeutics, Inc.|Short-Term Debt to Equity Pasithea Therapeutics Corp|Cortigent Medical - Current Liabilities to Equity|Short-Term Debt to Equity Avenue Therapeutics, Inc (ATXI)|BCLI (BrainStorm Cell Therapeutics Inc.) - Ratio of Short-Term Indebtedness to Capital|Cara Therapeutics, Inc. - Short-Term Debt to Equity Ratio|CHRO: Short-Term Debt to Capital Ratio|ELYM - Short-Term Debt to Equity|ITCI (Intra-Cellular Therapies) - Short-Term Debt to Capital Ratio|LBPH: Short-Term Debt to Capital|Current Liabilities to Capital Marinus Pharma (MRNS)|Short-Term Debt to Equity Ratio NKGN|Short-Term Debt to Capital neurobopharma.com|Short-Term Debt to Equity Sage Therapeutics (SAGE)|SNPX (Synaptogenix Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Trevena, Inc TRVN|Vigil Neuroscience Inc. (VIGL) - Current Liabilities to Capital|Anew Medical, Inc. - Short-Term Debt to Capital|cerevel.com (CERE) - Short-Term Debt to Equity Ratio